Squamous Cell Non-small Cell Lung Cancer

• CLINICAL_TRIALS research · 2026-03-19
  Clinical Trial Update: A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors [Phase 1, Phase 2]

  A Phase 1/2 clinical trial update shows ALE.P03 as monotherapy being studied in adults with selected advanced or metastatic CLDN1+ solid tum…

• CLINICAL_TRIALS research · 2026-03-17
  Clinical Trial Update: GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors [Phase 1, Phase 2]

  This clinical trial update reports that GI Innovation is studying GI-101 and GI-101A as single agents or in combination with pembrolizumab o…

• CLINICAL_TRIALS research · 2024-12-27
  Clinical Trial Update: Efficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical Study [Phase 2]

  This Clinical Trial Update describes a Phase 2, single-arm multicenter study evaluating the combination of sintilimab with nab-paclitaxel an…

• CLINICAL_TRIALS trial_result · 2024-03-20
  Clinical Trial Update: Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer [Phase 2, Phase 3]

  Phase 2/3 trial update evaluating JMT101 with docetaxel in squamous cell non-small cell lung cancer; not yet recruiting.

• CLINICAL_TRIALS trial_result · 2024-02-09
  Clinical Trial Update: SCT-I10A or Placebo Plus Docetaxel With Previously Treated Squamous Cell Non-small Cell Lung Cancer [Phase 3]

  Phase 3 trial SCT-I10A plus docetaxel versus placebo in previously treated squamous cell non-small cell lung cancer was terminated.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-12-14
  Clinical Trial Update: Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC（neoSCORE Ⅱ） [Phase 3]

  Phase 3 trial evaluating neoadjuvant sintilimab plus chemotherapy for resectable squamous cell non-small cell lung cancer is recruiting.

• CLINICAL_TRIALS trial_result · 2016-03-17
  Clinical Trial Update: Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017) [Phase 3]

  Phase 3 trial comparing nivolumab to docetaxel in previously treated advanced/metastatic squamous cell non-small cell lung cancer has comple…

• CLINICAL_TRIALS trial_result · 2015-10-22
  Clinical Trial Update: Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens [Phase 2]

  Phase 2 trial of nivolumab in advanced or metastatic squamous cell non-small cell lung cancer after at least 2 prior regimens completed; res…